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Abstract
Background: Self-monitoring of blood glucose (SMBG), including self-regulation, is an important tool to achieve
good glycemic control. However, many patients measure their glucose concentrations less often than is
recommended. This study investigates patients’ perspectives of SMBG and all relevant aspects influencing SMBG in
patients with type 1 and insulin-treated type 2 diabetes.
Methods: In depth interviews were conducted with 13 patients with type 1 diabetes from an outpatient clinic and
15 patients with type 2 diabetes from general practices. All interviews were transcribed verbatim and analyzed
using the Grounded Theory approach.
Results: A wide variety of SMBG was encountered. Perceptions, goals of SMBG and personal and contextual factors
were identified, influencing the respondents’ perspective of SMBG, and leading to this variety. Respondents
experienced a discrepancy between their own and the professionals’ perceptions and goals. Respondents’
perception of SMBG ranged along a continuum from ‘friend’ to ‘foe’. With respect to the goals, the respondents
experienced tension between achieving good glycemic control and quality of life, and deliberately made their own
choices. The performance of SMBG was tailored to their perceptions and personal goals. Personal and contextual
factors such as hypo- or hyper (un)awareness, knowledge, and contact with professionals acted as either facilitating
factors or as barriers to SMBG, depending on the respondents’ perspective. A SMBG model was developed
providing a representation of the factors and their interrelations.
Respondents with type 1 diabetes seemed more resigned to their situation and SMBG was more integrated into
their lives.
Conclusions: From the patients’ perspective, professionals positively present SMBG as a ‘friend’ in order to achieve
strict glycemic control. Whereas patients can also perceive SMBG as a ‘foe’. They primarily seek a personal balance
between achieving glycemic control and quality of life, leading them to deliberately make other choices regarding
SMBG performance than was recommended. Gaining insight and discussing all factors affecting SMBG will help
professionals and patients come to mutually agreed goals and to tailor the performance of SMBG to the individual
patient. This should result in a more optimal use of SMBG, an improved quality of life, and improved clinical
parameters.
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The Diabetes Control and Complication Trial [1] and the
United Kingdom Prospective Diabetes Study [2] demon-
strated that strict glycemic control significantly decreases
the risk of long-term diabetes complications. In order to
obtain good glycemic control, self-monitoring of blood
glucose (SMBG) is essential in insulin-treated patients
with diabetes [3-5]. SMBG includes an assessment of the
capillary glucose concentration (self-measurement) as
well as the interpretation of and responding to the read-
ings (self-regulation). The goal of SMBG is to achieve
blood glucose levels as near to normal as possible in
order to prevent long-term complications, to be able to
take adequate decisions in relation to diet, exercise, and
medication, to evaluate the effects of these decisions, and
to detect hypo- and hyperglycemia [6,7].
Many patients, however, monitor their blood glucose
less than is recommended by their healthcare provider
[8-10]. Quantitative research shows several barriers to
SMBG. These include a longer duration of the disease,
pain, low self-efficacy, low self-esteem, increased anxiety
and depression, alcohol abuse, smoking, complex treat-
ment regimes, decreased social supports, poor communi-
cation between patients and health care providers, lack of
education, and lack of health insurance [8,10-16]. Quali-
tative research on patients’ perspectives on SMBG,
including the barriers and facilitating factors is scarce
[17-20]. In these studies other barriers to SMBG have
also been identified such as an increased awareness of
their diabetes, physical discomfort, not understanding the
relationship between SMBG values and the behavior of
the patient, not knowing how to correctly respond to the
glucose readings, and being in poor glycemic control.
However, in most of these studies the focus is mainly on
patients with type 2 diabetes, not treated with insulin.
More qualitative research is needed to increase the
insight into perspectives of SMBG in insulin-treated
patients with diabetes. These insights can help profes-
sionals support the patients in their self-management
regarding SMBG [16,20,21].
The objective of this qualitative study is to investigate
the perspectives of patients with type 1 and insulin-trea-
ted type 2 diabetes regarding SMBG, including the bar-
riers and facilitating factors in performing SMBG, and
whether differences in perspectives exist between
patients with type 1 and type 2 diabetes.
Methods
Our intent was to move beyond description and to iden-
tify and explain factors which affected the patients’ per-
spectives of SMBG. The grounded theory approach
provides a methodological framework to develop theory,
including a model, that interprets the data [22-24].
Patients
Patients with type 1 diabetes were recruited from the
outpatient clinic of a general hospital in the Nether-
lands, and patients with type2d i a b e t e sf r o mg e n e r a l
practices in the same region (Isala Clinics Zwolle, the
Netherlands). Eligibility criteria were: a diagnosis of type
1 or type 2 diabetes, treated with insulin, SMBG carried
out for a minimum of one year, Dutch speaking, and
over the age of 18.
The initial selection focused on building a patient
population with as much variation as possible in the fac-
tors relating to SMBG. Physicians and diabetes specia-
lized nurses were asked to select patients who differed
in age, gender, living status, education, type of diabetes,
insulin therapy, duration of SMBG, and employment.
When the patient expressed an interest in participation,
printed information was provided. The researcher then
followed up by telephone to answer any remaining ques-
tions and to make an appointment with the patient. The
patient population ultimately consisted of 28 patients,
13 patients with type 1 and 15 patients with type 2 dia-
betes. The demographic and background characteristics
of the patients are presented in Table 1.
The patients were informed that their anonymity was
guaranteed and that all information gathered would be
confidential by disassociating the patient name from the
data. Each patient received a research number, and the
data were saved under this number. Approval for the
Table 1 Characteristics of the patients
Description DM 1 (n = 13) DM 2 (n = 15)
Male 5 8
Age (years) 45 (40-58) 71 (60-76)
Marital status
Married/cohabiting 11 11
Single 2 4
Education:
Low
a 31 0
Middle
b 85
High
c 2
HbA1c (mmol/mol) 57 (55-63) 58 (53-66)
Diabetes duration (years) 19 (13-28) 11 (5-16)
Type of insulin therapy:
1 insulin injection per day 7
2 insulin injections per day 3
4 insulin injections per day 3 5
insulin pump 10
Duration of SMBG (years) 19 (13-24) 8 (4-13)
Data are n or, due to skewed distribution, median (P25, P75)
aLow: primary school, lower secondary general, lower vocational
bMiddle: higher secondary general education, intermediate vocational
cHigh: higher vocational education, university
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Committee of the Isala Clinics in Zwolle (NL
27433.075.09). All patients provided written informed
consent.
Data-collection
Data were collected through the conduction of one-time
open in depth interviews, guided by a topic list. This
topic list was compiled based on literature, including
the General Self-management Model which is based on
the Chronic Care Model [25,26] as well as topics gath-
ered during two focus group meetings. These meetings
were held with patients who attended the same outpati-
ent diabetes clinic in a hospital setting. The first group
consisted of eight patients with type 1 diabetes: five men
and three women with a median age of 52 years (Inter-
quartile range (IR):37-61), and a median diabetes dura-
tion of 25 years (IR:5-39). The second group consisted
of eight patients with type 2 diabetes: four men and four
women with a median age of 68 years (IR:48-76), and a
median diabetes duration of 10 years (IR:9-16). The
focus group interviews were led by the principal
researcher (JH) and a psychologist (WSW). These inter-
views also increased the principal researcher’s prepared-
ness to conduct the individual interviews. Focus group
patients were not included in the individual interviews.
The following topics were incorporated in the indivi-
dual interviews: the frequency of SMBG, its goals, the
effect on daily life, knowledge, patient skill level, confi-
dence in self-care, living with diabetes, the patient’s con-
tribution to treatment, the role of relatives, the role of
healthcare providers, as well as any barriers and facilita-
tors for performing SMBG.
The question posed to the patients to initiate the in
depth, open interviews was: ‘What does it mean to you
to perform SMBG?’ A non-judgmental atmosphere was
strived for with a clear emphasis placed on the fact that
the investigator was there to learn from the patients. As
the study progressed, the focus of the interviews shifted
toward the specific issues which were identified
throughout the data analysis. Theoretical sampling con-
tinued until no new ideas arose which were of value to
the developing theory, and saturation was reached.
The interviews were held either at the patient’s home,
at the Isala Clinics or at the general practice according
to the patient’s preference. They were conducted by the
principal researcher, an experienced nurse specialized in
diabetes (JH). She had had no prior professional contact
with the patients.
Data-analysis
Interviews were tape-recorded and transcribed verbatim.
MAXqda 2007 was used for the analysis of the interview
data. The data-analysis consisted of three phases of
coding [22-24]: initial coding by breaking down the data
(open coding), reconnecting the broken data into cate-
gories (axial coding), and interconnecting the categories
into a model that represents the factors related to the
patients’ perspectives of SMBG (selective coding). The
coding and categorising involved constant comparison.
The principal researcher coded and categorised the data.
Three other researchers individually read the interviews
and the coding results, and/or were involved in develop-
ing the theory. The researchers had different back-
grounds and therefore contributed to alternative
perspectives, thereby preventing going native. During
meetings, consensus about the coding, categories and
the developing theory was achieved. This researcher tri-
angulation procedure served to increase the depth of the
analysis and established increased validity. Memos were
used in which the ideas were written down about the
evolving theory. Validation was enhanced by member
check and peer review. Four of the respondents were
asked to verify the written summary of their interviews.
All four confirmed that the summaries were a fair repre-
sentation of their perspectives. Provisional conclusions
and theoretical insights were discussed with a person
from the Dutch Diabetes Association and a diabetes spe-
cialized nurse.
Results
The respondents’ perceptions, their goals, and several
personal and contextual factors were identified as impor-
tant factors which affected the patients’ perspectives of
SMBG. These factors led to a wide variety of perfor-
mances, and did prove to be interrelated. In Figure 1, a
SMBG model is presented which represents the respon-
dents’ perspectives, the influencing factors and how they
interrelate. Our analysis revealed that the difference in
perspectives between men and women was that feelings
of shame towards health care providers about ‘poor’ read-
ings were only reported by women. First, a description of
SMBG in daily practice is provided followed by a review
of the factors.
Variety in SMBG performance in daily practice
The individual performance of SMBG differed with
respect to frequency, timing, the actual measurement,
interpretation of the readings, the resulting action taken,
and an evaluation of the outcome. The respondents
made their own choices regarding the performance, and
they had their own reasons and logic for the choices
they made. A wide variety in SMBG performances was
seen in this study as a result. 15 respondents reported
that their frequency of SMBG use was according
to the recommendations provided by their health care
provider, 3 respondents reported a lower frequency,
3 respondents reported a higher frequency, and 7
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recommendations. In addition, a majority of all the
respondents reported that their frequency and timing of
SMBG varied from day to day.
’I measure my blood sugar every morning. If it’s a bit
low, around 6 or so, and I know that I don’th a v ea
lot planned for the day, then I don’t worry about it.
If we are going out somewhere, however, then I think
about what we are going to do, and I measure it
more often, and I will already have an extra slice of
bread in the morning. I think ahead. I don’t like feel-
ing hypoglycemic. I want to prevent that. Even, if I
am just going somewhere by car, I will do an extra
measurement. Imagine if I was to get an hypoglyce-
mia. There are already enough people in the ditch.’
Respondents differed in their interpretation of the
readings, the subsequent actions taken, and their evalua-
tion of the outcomes of these actions. For example, a
high glucose concentration could lead the patient to
adjust the insulin dosage, change the food intake, con-
tact the health care provider or to take no action and
adopt a wait-and-see policy.
’I had the self monitoring glucose meter, but I didn’t
do a lot with it. I figured that things were actually
going pretty well. I measured my blood sugar about
once per month, and if the results were good, then I
thought: things are fine. If the results were not good,
then I thought: well, what can I do about it? I don’t
know. I was being followed by both my family doctor
and a nurse specialized in diabetes. My weight was
good, I didn’t have too much belly fat,... so I figured
that things were going all right. So I just waited to
see what the next month’s results would bring.’
The perception of SMBG: a continuum between ‘friend’
and ‘foe’
Some respondents perceived SMBG as a ‘friend’, giving
them confidence, freedom, certainty and peace of mind.
It helped them to achieve their personal goals including
good glycemic control, autonomy, control of their
diabetes, and the ability to lead a normal life.
’I measure my blood sugar to see if it stays some-
where between 5 and 8. And it is the expectation
that you check your own levels once a week. That is
the agreement. That gives me a good feeling. Some
people get very anxious when they have to prick their
finger. Not so for me. On the contrary, it gives me a
feeling of security.’
In respondents who were no longer familiar with the
symptoms of hypo- and hyperglycemia, SMBG was felt
to be helpful in prevention and detection. Most respon-
dents, who perceived SMBG in a positive way, reported
that it had become a habitual part of their daily lives.
Other respondents perceived SMBG more as a ‘foe’.
They mentioned many experiences to support this per-
ception. For example, the finger prick can be painful
and can lead to callous and hard spots.
’It is not easy to get a drop of blood. I have got hard
black marks on his hand. The marks are so conspicu-
ous. I sometimes find that I am confronted by them.
When I am 60 or 70 years old I worry that I won’t
Figure 1 Model: Self-monitoring of blood glucose.
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that your fingers will be totally covered with
callous...’
Some respondents felt obliged to monitor their glu-
cose levels with SMBG. When they decreased the fre-
quency of SMBG, their glucose regulation worsened,
and they had a higher risk of developing an unnoticed
hypo- or hyperglycaemia. Furthermore, when the read-
ings were not in accordance with the expectations, espe-
cially unexpected ‘poor’ readings, respondents reported
feeling frustrated, anxious, ashamed, or helpless. Some
respondents felt that they were never free from their
diabetes, always feeling that they had to focus on it.
According to these respondents SMBG required a lot of
organizational effort and interruption of their regular
activities. They felt they had to carry a lot of things with
them whenever they would go out in order to be able to
measure their glucose concentration.
’Always having to think: did I remember this? Did I
remember that? My pockets are always stuffed full of
all kinds of things. It’s annoying. My purse is like a
moving van. I can’te v e rg oo u tw i t has m a l ln e a t
purse. Not even when I go to the opera house.’
The respondents’ perception of SMBG appeared to be
a dynamic factor. For example, adjustments in materials
e.g. another kind of finger-pricking device, could make
blood glucose testing easier and less painful. This led to
a more positive perception. The perception of SMBG as
a friend or a foe was related, to some extent, to the fre-
quency of measurement. Respondents who perceived
SMBG as a foe, did not always measure their blood glu-
cose concentration less often than those who perceived
SMBG as a friend, but they did encounter more difficul-
ties with the measurements.
Personal goals: tension between good glycemic control
and quality of life
From the interviews, it became clear that the respon-
dents were not only focused on good glycemic con-
trol. They were also focused on maintaining their
quality of life.
To achieve the desired glycemic control in order to
prevent complications, respondents reported that they
had to measure their glucose concentrations frequently
in order to make the required adjustments in insulin
dose, food intake, and lifestyle. Furthermore, these fre-
quent measurements were necessary for the prevention
and detection of hypoglycemia.
’My sugar levels are regularly on the low side. If you
are tightly controlled, that’s what happens. I am
hypoglycemic at least once per day. I would rather
live this way with a lower average than be hypoglyce-
mic less often with a higher average. I always think
that if your levels are high then the disease keeps nib-
bling pieces off of your blood vessels. It’sl i k eat i m e
bomb which you can’t give too many chances. The
price is that you are then hypoglycemic with some
regularity.’
Respondents described their quality of life in terms of
maintaining autonomy, living a normal life, enjoying life,
not having to always focus on their diabetes, not being
considered a patient, and not wanting to be a burden to
their relatives. The influence of quality of life on the fre-
quency of SMBG was less clear than the influence of
good glycemic control. It depended on how the respon-
dents individually interpreted quality of life. For exam-
ple, the concept of living a normal life could mean that
the respondent did not want to focus exclusively on the
diabetes, which would lead tom e a s u r i n gt h eb l o o dg l u -
cose concentrations less often. However, it could also
mean that the respondent would measure the blood glu-
cose more frequently in order to keep the diabetes
under control so that he/she would be able to do the
activities he/she was used to doing.
Many respondents set their own personal target values
with the goal of preventing either a hypoglycemia or a
hyperglycemia. Many respondents experienced a hypo-
glycemic state as being quite distressing. They felt that
it kept them from living a normal life and from having
their diabetes under control. These respondents were
willing to accept higher glucose readings. Other respon-
dents primarily wished to prevent a hyperglycemia to
prevent complications. They accepted being hypoglyce-
mic more often.
’When I am hypoglycemic, I feel wretched. I even
notice that I can become quite aggressive. I don’t
really have a problem with high sugar levels, but the
low ones are quite bothersome. I really try to avoid
attacks of hypoglycemia. I become quite anxious
about them. You also don’t want to get aggressive.
It’s very unpleasant and actually you totally don’t
want that.’
Achieving a good quality of life and satisfactory glyce-
mic control were sometimes in alignment with each
other. For example, respondents reported feeling better
when their glucose levels were better. However, a major-
ity of the respondents experienced tension between
achieving both these goals simultaneously. They tended
to deliberately make their own choices regarding the
goals of SMBG, and tailored their performance of
S M B Gt ot h e s eg o a l s .T h e yw e r ea w a r eo ft h e
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mendations they had received from their health care
providers.
Personal and contextual factors: barriers or facilitators
Personal and contextual factors may act as barriers or
facilitators in the performance of SMBG, depending on
the respondents’ perspective. Furthermore, these factors
could result in goal adjustments and a shift in the per-
ception of SMBG rendering it more positive or negative
for the patient.
Personal factors
Personality Respondents explained that their perfor-
mance of SMBG was a result of their personality make-
up including such things as perfectionism, being down
to earth, or being easily worried. Some respondents
reported that these traits were influenced by their
upbringing, such as not being allowed to complain.
Their personality influenced their goals, their percep-
tions and their SMBG performance.
’I’m a bit of a perfectionist, and I aim for really good
glucose levels. And then I’m really scared that if, one
time, I do forget, that my sugar level will shoot up.
So then you start self-monitoring again...’
Acceptance Some respondents mentioned that they had
trouble performing SMBG as it forced them to confront
and accept their diabetes in a concrete and visible way.
One respondent reported that psychological factors
played a role, as he did not want to have to make
changes in his life or give things up. As a result, he
measured his blood glucose less frequently.
Depression Some respondents reported having been
depressed. This did not always directly influence their
SMBG behaviour, but it did influence the goals sur-
rounding their measurements. They did tend to accept
higher glucose concentrations. They strived for keeping
control of their diabetes by preventing hypo- and hyper-
glycemic symptoms. They wer en o ta b l et os t r i v ef o r
optimal glycemic control.
’In that period of depression I was just happy when I
felt good and that things were moving again, and
that I could do my job again and things like that,
and for me that was enough. The diabetes just
wasn’t that important for me. I actually made the
choice to just let it be there for what it was. Not that
I became negligent about it, absolutely not, but...
well, slowly but surely, as my life got back on track
and other things became more normal again, then I
could start refocusing on the diabetes.’
Awareness of hypo- and hyperglycemic symptoms The
loss of awareness of hypo and hyperglycemic symptoms
acted both as a barrier and a facilitator in the measure-
ment of glucose levels. Some patients reported that they
were no longer aware of the symptoms. They found that
performing SMBG helped them to prevent and detect
any extreme states. In this case the lack of awareness
acted as a facilitator.
’It is difficult for me to estimate how high my glucose
levels are. Some people do this perfectly, but I defi-
nitely cannot. So, I can guess, and just do whatever.
But if my estimate is far off, and the level is either
much higher or much lower, then it is no good to me.
So, I keep measuring five times per day.’
Other respondents reported that they did not have
hypo- or hyperglycemic symptoms. They did not feel
the need to test because they felt good. These respon-
dents could have no hypoglycemia or hyperglycemia.
But it could also be a lack of awareness. Awareness of
the symptoms showed a similar duality. There were
respondents who used SMBG as a check to confirm
their symptoms, where the awareness acted as a facilita-
tor. Other respondents did not need confirmation,
because they already felt the symptoms.
’When things are fine in the morning, and I feel good
that day, I don’t worry about testing. I go with how
I’m feeling. And that works for me.’
Knowledge, including misconceptions According to the
respondents, their knowledge regarding self-monitoring
had increased as a result of their own experience, educa-
tion, reading the provided literature, and listening to the
anecdotal experiences of other patients. Some respon-
dents reported that the initial phase was of particular
importance as it formed the foundation for their goals
and perceptions.
’I was told: you can live a normal life with diabetes.
That’sw h yIw a s n ’t focused on properly regulating
my blood sugar and doing my own monitoring. For
m eIf e l ti tw a sal i c e n s en o tt ob ef o c u s e do nm y
diabetes. This effect may persist for a long time.’
It became clear from the interviews that experiential
knowledge played an important role in the use of
SMBG. Most of the respondents had been using SMBG
for a number of years. They felt that they were unique
in the way that they reacted to it. They had learned
from their experiences and knew what was realistic for
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able to others. This could lead to frustration.
’But the stories you hear such as be careful with exer-
cising because your blood sugar can go down as
much as one point. Then you’ll see that with me, it
actually goes up. Everything is different than what I
hear. That is also what frustrates me so much. I
can’t explain it.’
For other respondents this uniqueness led to resigna-
tion to their current situation. Better glycemic control
was not possible for them.
’The doctor told me: “all right, your glucose concen-
trations are now between 10 and 15 mmol/l. Just try
to get the readings between 6 and 10 or 11. That
would be quite an improvement.” But that is quite a
step forward. Some days everything is going all right
and I have good glucose concentrations. But I just
accept that this is not always the case. I just know
that for me it is difficult to achieve good glycemic
control. I do not try to get better readings. It will
never be perfect and it is better to accept that.’
There were some respondents who mentioned that
they had had misconceptions. For example, what consti-
tuted a good value? In almost every public advertise-
ment for a blood glucose meter, a value of
approximately 5.8 mmol/l was depicted on the meter.
Although other target values had been discussed with
the health care provider, several of the respondents
reported that they nonetheless wanted to achieve these
published values which led to a high frequency of glu-
cose monitoring. They then felt frustrated when they
were not able to achieve these results. Others were able
adjust their expectations once they had consulted with
their health care provider.
Life-events Major life-events, such as having a baby, can
cause patients to be more concerned about their glyce-
mic control, which in turn leads to a higher frequency
of glucose monitoring. Other events, such as a serious
illness in the family, can act as distractors from the dia-
betes, leading to a decreased frequency of monitoring.
Contextual factors
Social support T h es o c i a ls u p p o r td e s i r e db ym a n yo f
the respondents was described as ‘being concerned with-
out intervening’.D i a b e t e si sp a r to ft h er e s p o n d e n t s ’
personal lives. They have to deal with it themselves.
Because they do not want to burden the people in their
social environment, they use SMBG to keep the diabetes
under control. They would like support in the form of
recognition of the impact of having diabetes and having
to perform SMBG. Furthermore, although contact with
other patients with diabetes was sometimes found help-
ful, there were also respondents who did not relate to
the perceptions and behaviours experienced by other
patients.
Contact with healthcare provider: discrepancies in
perspectives ’They really want you to do everything to
achieve good glycemic control. The stricter the better.
But then I think: That all sounds pretty good on
paper, but for me it’s like well, ok, you feel better
with somewhat higher sugar levels? Yes, actually I
do. Well, then I’ll do it this way.’
Many respondents reported feeling a certain tension
between their goals and perceptions of SMBG and that
of their health care providers. According to the respon-
dents, professionals focused more on strict glycemic
control, whereas the respondents had to balance glyce-
mic control with their quality of life. Respondents men-
tioned that professionals could support them in their
self-monitoring practices by paying attention to the
patients’ goals, perceptions, and their readings (not only
to HbA1c levels). If the health care professionals were
to recognize the uniqueness of the individual patient
and tailor the care and the design of glucose regimens
to them, the patient would feel better supported.
Some respondents reported feeling ashamed that they
did not meet the goals set for them by their health care
provider, and that they were obtaining ‘poor readings’,
despite the effort they were putting into it. Sometimes
they did not report their results, because they were
afraid of the negative response they would receive from
the health care provider. Others did not discuss their
measurements and did not bring up questions and con-
cerns, as they were afraid that they would have to
change their lifestyle as a result. Other respondents
claimed to be nonchalant, and accepted that their mea-
surements would not be discussed.
’I’m bad at keeping track. I measure, but I don’t keep
track. So when I visit the doctor, I come without a
record. The doctor only looks at the average values
and those are good. Whereas I know, and I think I’ve
mentioned it to the doctor, that it’s because of the
peaks and valleys that the average ends up good. But
nothing was done with this information. Nothing
changed until the moment that I, myself, started say-
ing, come on guys, something has to be done. Then
things started happening, and they started thinking
along with me. Before now, I left things as they were
as well. I was pretty nonchalant. I figured, if the
average value was good, and I had the feeling that
the morning began well, and the evening ended well,
everything was okay. If everything was approximately
correct, no harm was being done.’
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ble for their health and for taking care of their diabetes
including self-monitoring. Health care providers could,
however, provide support, but when the respondents
were not satisfied with the delivered care, they seldom
discussed it with the health care provider, because they
wanted to preserve a positive atmosphere.
Differences between patients with type 1 and type 2
diabetes
There were a number of similarities between the
respondents with type 1 and type 2 diabetes, but the
emphasis on separate factors was sometimes different.
Respondents with type 2 diabetes were less focused on
adjusting the insulin dose. They were more focused on
adjusting food intake and their lifestyle, including exer-
cise. Usually, they only changed their insulin dose in
consultation with the health care provider. They were
more sensitive to the advice of their health care provi-
ders, and they were more attentive in general. Further-
more, their glucose monitoring showed more variation
in both timing and frequency. They were more likely to
report that they wanted to enjoy their lives without hav-
ing to continually focus on their diabetes. Respondents
with type 1 diabetes performed SMBG with greater reg-
ularity and an increased frequency when compared to
the patients with type 2 diabetes. The diabetes was also
more of an integral part of their lives.
Respondents with type 2 diabetes experienced more
complications associated with their diabetes, although
this did not seem to have a great effect on the fre-
quency with which they monitored their blood glucose.
They also experienced more frustration, not under-
standing unexpected readings when they monitored
their blood glucose. Respondents with type 1 diabetes
seemed to be more resigned to their glycemic control.
Finally, respondents with type 1 diabetes reported more
often that they were no longer aware of hypo- and
hyperglycemic symptoms. As result, they felt more
dependent on SMBG for feedback about the status of
their diabetes.
Discussion
SMBG from the patients’ perspective
This study investigated the patients’ perspective of
SMBG. The outcomes of our study show that there
is a wide variety in the performance of SMBG, as a
result of a complexity of factors. These factors
include the patients’ perception, his/her goals, and
personal and contextual factors. Patients did not
always perceive SMBG as a positive tool, which
would enable them to achieve good glycemic control.
Patients mentioned many experiences which support
a negative perception of SMBG, which made it more
difficult to perform SMBG. They also felt that health
care providers were predominantly focused on good
glycemic control. The patients experienced the ten-
sion between achieving good glycemic control and
quality of life. As a result, the patients tailored the
performance of SMBG to their perceptions and per-
sonal goals. Personal and contextual factors were
identified as being either barriers or facilitators to
SMBG depending on the patients’ perspective. Most
of these factors proved to be dynamic, as they were
apt to change over time, sometimes as the result of
an intervention by the health care provider. We
developed an SMBG model which gives a representa-
tion of all the identified influencing factors and their
interrelations.
The SMBG model is a specialized version of the Gen-
eral Self-management Model, which gives a representa-
tion of the factors, which must be considered when
discussing self-management [25]. The SMBG model
gives additional information and more practical content
to the factors. Furthermore, the factors are arranged in
a different way. For example, in the general model, the
interaction between the patient and the health care pro-
vider plays a central role. In the SMBG model, this rela-
tionship is only one of the contextual factors which
influences the patients’ perspective.
Factors identified in our study such as pain, frustra-
tion, depression, knowledge level, treatment complexity,
social support, and contact with the health care provider
have also been reported in previous studies, including
the recent study of Fisher et al. [8,10,12-21,27,28]. Fisher
has investigated the knowledge and behavioural skills in
more detail [15]. He concluded that more research is
necessary to understand the factors, especially among
patients with type 2 diabetes. Our study does offer a
broad perspective and more insight into the influencing
factors and the relationship between them among
patients with type 1 and insulin-treated patients with
type 2 diabetes. For example, we show that whereas
patients with depression tend to tailor their self-moni-
toring goals to their life situation, the frequency of
SMBG did not always change. In our study, the patients’
perception of SMBG is described as a separate factor,
and is presented as occurring on a continuum from
positive to negative. We investigated the deliberate
choices made by patients regarding the goals and perfor-
mances of SMBG, and looked at the logic which gov-
erned their decisions.
In other studies, factors have been reported as being
either barriers or facilitators to the performance of
SMBG. Our study revealed that there are additional
nuances which must be considered. Personal and con-
textual factors had either a positive or a negative effect,
depending on the patients’ perspective.
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SMBG is not only positively presented in professional
guidelines [6,7,29,30]. Manufacturers also present
SMBG as a tool with which diabetes may be con-
trolled, thereby allowing patients to live a normal life.
In their advertisements, the readings on the glucose
meters usually give values of approximately 5.8 mmol/l
while people in the commercial are smiling, looking
relaxed and are enjoying life. The meters appear user
friendly, the results are almost instantaneous, and
apparently almost anybody can use them. Our findings
agree with those reported in other studies, including
one study in children with diabetes, that SMBG in
daily practice is not just a small effort, and it does not
always guarantee the pleasure seen in the commercials
[13,31]. From the patients’ perspective, SMBG is more
complex, and the diabetes is often considered difficult
to manage. These overly positive representations do
not do justice to the visible and invisible work that
patients with diabetes have to do nor do they acknowl-
edge the unexpected and sometimes negative readings
with which the patients are sometimes confronted
despite their efforts. Patients with diabetes need recog-
nition for these efforts and recognition for the impact
that SMBG has on their daily lives.
Contact with the health care provider: duel or duet?
Increasingly, in health care, persons with a chronic dis-
ease are given a more central role in their treatment.
The patient is responsible for the way in which he/she
deals with the disease process. He/she is co-director of
his/her own care plan, and is expected to be actively
involved. This includes being able to discuss his/her
own interests and needs and organizing his/her own
care. With an individual care plan, mutually agreed
goals and a treatment plan should be outlined with
shared responsibilities. This approach should result in
improved health care outcomes and lower costs
[8,29-34].
However, in our study, as well as in Dedding’s study, a
discrepancy in perspectives was found between the
patients and the health care providers [31]. According
to the respondents, health care providers sometimes set
unachievable goals, and persisted in trying to motivate
them to attain these goals. While many patients
accepted that better glucose concentrations were not
feasible for them. Furthermore, the advice did not
always concur with the patients’ needs. As a result,
patients ended up making their own choices regarding
blood glucose monitoring. Patients tend not to discuss
the poor support or the dissatisfying aspects of their
treatment as they are afraid that it would negatively
influence either the atmosphere or the treatment itself.
Health care providers need to be aware of this so that
they can take into account the patients’ need to preserve
the provider-patient relationship [31,35].
Differences between patients with type 1 and type 2
diabetes
Vincze et al. reported that patients with type 1 diabetes
are more adherent to SMBG than patients with type 2
diabetes. Patients with type 2 diabetes may be less con-
vinced that regularly testing blood glucose levels would
lead to positive outcomes [10]. Our study shows that
patients with type 1 diabetes were not specifically more
adherent to blood glucose monitoring, but they did
seem more resigned to their situation, and were more
likely to view SMBG as an integral part of their lives.
Additionally, more factors were identified which influ-
enced the patients’ perspectives of SMBG. For example,
patients with type 2 diabetes experienced more frustra-
tion when they obtained unexpected results.
Implications for daily practice
In daily practice, health care providers also have to find
a balance between achieving good glycemic control and
quality of life. Glycemic control is recommended in the
guidelines, it helps prevent long term complications, and
is an important indicator for the quality of health care.
The patient’s quality of life is equally as important. The
challenge for the health care provider is to set, in dis-
cussion with the patient, glycemic goals which are as
strict as possible while maximizing the patient’s quality
of life. It is not a matter of only listening to the patient’s
perspective, including his/her goals and needs, but it is a
starting point.
The SMBG model can help professionals and patients
to understand and discuss each other’sp e r s p e c t i v e si n
order to be able to set mutually agreed upon, realistic,
and achievable goals. Furthermore, it is important that
professionals discuss both the positive and the poten-
tially negative aspects of SMBG from the very start
including how to deal with SMBG on a daily basis. This
will serve to enhance the patient’s feelings of personal
control and help to cope with the inevitable disappoint-
ments, thereby enhancing positive perceptions of SMBG
[16,21,36-38]. The performances can also be individually
tailored to the patient. This will allow an optimization
of SMBG use and will prevent both unnecessary mea-
surements and costs. After all, there is no evidence sup-
porting a specific frequency of SMBG, which has led to
a variety of recommendations in the literature [6,29,30].
SMBG is not a goal in and of itself, but a tool which
should be used to achieve optimal glycemic control in
an effort to prevent long term complications [21]. Edu-
cation and training will likely be necessary before the
health care providers can optimize their use of this
approach and attitude [8].
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of the factors affecting the SMBG model are dynamic.
F i n a l l y ,an e ws t u d yi ss t a r t e dt od e v e l o pa n dv a l i d a t e
a clinical measurement tool of patients’ perspective of
SMBG.
Strengths and limitations of the study
Our patient population consisted of native Dutch
patients, therefore the results can not be extrapolated to
patients of different ethnicities. Although we followed
the principles of purposeful and theoretical sampling,
the study participants were asked to participate by their
own health care provider which may have led to a selec-
tion bias. On the other hand, we were able to select a
widely diverse sample. The maximum variation of rele-
vant characteristics made it possible to make full use of
comparative analysis theory. Our study not only con-
firms what has been reported in previous studies, but
provides a deeper insight into the perspectives of insulin
treated patients with diabetes.
Conclusions
According to the patients, professionals are positive
about the use of SMBG as a tool in order to achieve
strict glycemic control. Patients can also, however, per-
ceive SMBG in a negative light. They have to find a bal-
ance between achieving glycemic control and
maintaining acceptable quality of life. As a result, the
patients’ use of SMBG is not always in concordance
with the recommendations from the health care provi-
der. Patients with type 1 diabetes appeared to be more
resigned to their situation and monitoring their blood
glucose was a more integral part of their lives than it
was for patients with type 2 diabetes. Gaining insight
and discussing all the factors involved with SMBG,
including personal barriers and facilitators, will help
health care providers and patients mutually agree on
realistic and achievable goals w h i l et a i l o r i n gt h ep e r f o r -
mance of SMBG on an individual basis. This should
r e s u l ti nam o r eo p t i m a lu s eo fS M B G ,a ni m p r o v e d
quality of life, and improved clinical parameters.
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